Literature DB >> 21509049

Postmenopausal hypertension.

Licy L Yanes1, Jane F Reckelhoff.   

Abstract

Cardiovascular disease is the leading cause of morbidity and mortality in postmenopausal women. Hypertension is a major risk factor for cardiovascular disease. The mechanisms responsible for postmenopausal hypertension have not been completely elucidated. However, various mechanisms have been implicated to play a role. For example, there is evidence that changes in estrogen/androgen ratios favoring increases in androgens, activation of the renin-angiotensin and endothelin systems, activation of the sympathetic nervous system, metabolic syndrome and obesity, inflammation, increased vasoconstrictor eicosanoids, and anxiety and depression may be important in the pathogenesis of postmenopausal hypertension. There is also evidence that hypertension is less well controlled in aging women than in aging men, but the reasons for this gender difference is not clear. Postmenopausal hypertension is likely multifactorial. Future studies will be necessary to determine the contribution of these systems listed above in mediating postmenopausal hypertension and to design treatment strategies that encompass these mechanisms to improve the quality of life of postmenopausal women as they age.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21509049      PMCID: PMC3820162          DOI: 10.1038/ajh.2011.71

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  126 in total

Review 1.  Neural mechanisms and management of obesity-related hypertension.

Authors:  Murray D Esler; Nina Eikelis; Elisabeth Lambert; Nora Straznicky
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

2.  Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women.

Authors:  Rosario Rossi; Annachiara Nuzzo; Giorgia Origliani; Maria Grazia Modena
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

3.  Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade.

Authors:  Babbette LaMarca; Josh Speed; Lillian Fournier; Sara A Babcock; Hunter Berry; Kathy Cockrell; Joey P Granger
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

4.  Low-dose transdermal hormone therapy does not interfere with the blood pressure of hypertensive menopausal women: a pilot study.

Authors:  Márcia N de Carvalho; Fernando Nobre; Maria C Mendes; Rosana M Dos Reis; Rui A Ferriani; Marcos F Silva de Sá
Journal:  Blood Press Monit       Date:  2008-10       Impact factor: 1.444

Review 5.  Inflammation and endothelial dysfunction during aging: role of NF-kappaB.

Authors:  Anna Csiszar; Mingyi Wang; Edward G Lakatta; Zoltan Ungvari
Journal:  J Appl Physiol (1985)       Date:  2008-07-03

Review 6.  Metabolic syndrome after menopause and the role of hormones.

Authors:  Rogerio A Lobo
Journal:  Maturitas       Date:  2008-04-14       Impact factor: 4.342

7.  C-reactive protein levels and ageing male symptoms in hypogonadal men treated with testosterone supplementation.

Authors:  E J Giltay; A Haider; F Saad; L J Gooren
Journal:  Andrologia       Date:  2008-12       Impact factor: 2.775

Review 8.  Testosterone in obesity, metabolic syndrome and type 2 diabetes.

Authors:  R Stanworth; T Jones
Journal:  Front Horm Res       Date:  2009       Impact factor: 2.606

9.  Sympathetic nerve hyperactivity of essential hypertension is lower in postmenopausal women than men.

Authors:  A J Hogarth; J Burns; A F Mackintosh; D A S G Mary
Journal:  J Hum Hypertens       Date:  2008-05-08       Impact factor: 3.012

10.  Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension.

Authors:  Manfredi Rizzo; Egle Corrado; Giuseppe Coppola; Ida Muratori; Giuseppina Novo; Salvatore Novo
Journal:  Coron Artery Dis       Date:  2009-01       Impact factor: 1.439

View more
  62 in total

Review 1.  The effects of oestrogens and their receptors on cardiometabolic health.

Authors:  Eugenia Morselli; Roberta S Santos; Alfredo Criollo; Michael D Nelson; Biff F Palmer; Deborah J Clegg
Journal:  Nat Rev Endocrinol       Date:  2017-03-17       Impact factor: 43.330

2.  Influence of age and sex on the pressor response following a spontaneous burst of muscle sympathetic nerve activity.

Authors:  Lauro C Vianna; Emma C Hart; Seth T Fairfax; Nisha Charkoudian; Michael J Joyner; Paul J Fadel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

Review 3.  The role of 20-HETE in androgen-mediated hypertension.

Authors:  Cheng-Chia Wu; Michal Laniado Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-22       Impact factor: 3.072

4.  Chronic Estrogen Supplementation Prevents the Increase in Blood Pressure in Female Intrauterine Growth-Restricted Offspring at 12 Months of Age.

Authors:  Gwendolyn K Davis; Ashley D Newsome; Alyssa B Cole; Norma B Ojeda; Barbara T Alexander
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

5.  Protective effect of sex on chronic stress- and depressive behavior-induced vascular dysfunction in BALB/cJ mice.

Authors:  Shyla C Stanley; Steven D Brooks; Joshua T Butcher; Alexandre C d'Audiffret; Stephanie J Frisbee; Jefferson C Frisbee
Journal:  J Appl Physiol (1985)       Date:  2014-08-14

Review 6.  The uncertain effect of menopause on blood pressure.

Authors:  Valérie Tikhonoff; Edoardo Casiglia; Federica Gasparotti; Paolo Spinella
Journal:  J Hum Hypertens       Date:  2019-03-21       Impact factor: 3.012

7.  ETB receptor contribution to vascular dysfunction in postmenopausal women.

Authors:  Megan M Wenner; Kelly N Sebzda; Andrew V Kuczmarski; Ryan T Pohlig; David G Edwards
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-04-24       Impact factor: 3.619

8.  Androgen Receptor Blockade Differentially Regulates Blood Pressure in Growth-Restricted Versus Ovarian Deficient Rats.

Authors:  Gwendolyn K Davis; Suttira Intapad; Ashley D Newsome; Laura E Coats; Daniel R Bamrick; Norma B Ojeda; Barbara T Alexander
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

Review 9.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

10.  Perceived stress, sex and occupational status interact to increase the risk of future high blood pressure: the IPC cohort study.

Authors:  Emmanuel Wiernik; Hermann Nabi; Bruno Pannier; Sébastien Czernichow; Olivier Hanon; Tabassome Simon; Jean-Marc Simon; Frédérique Thomas; Cyril Ducolombier; Nicolas Danchin; Frédéric Limosin; Silla M Consoli; Cédric Lemogne
Journal:  J Hypertens       Date:  2014-10       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.